Answer: Sputnik V
Notes: The promoter of the Sputnik V vaccine candidate - Russian Direct Investment Fund (RDIF) has entered into an agreement with Hyderabad based company named “Hetero Biopharma”.
Under the agreement, the Sputnik V vaccine candidate would be produced in India from beginning of 2021. The Sputnik V vaccine is recently claimed to have reached an efficiency of 91.4% in Phase 3 trials.
